Hepatocellular carcinoma after direct-acting antiviral agents: Can liver stiffness kinetics help identify patients at lower risk?
- PMID: 29678415
- DOI: 10.1016/j.dld.2018.03.025
Hepatocellular carcinoma after direct-acting antiviral agents: Can liver stiffness kinetics help identify patients at lower risk?
Comment on
-
Hepatocellular carcinoma risk assessment by the measurement of liver stiffness variations in HCV cirrhotics treated with direct acting antivirals.Dig Liver Dis. 2018 Jun;50(6):573-579. doi: 10.1016/j.dld.2018.02.010. Epub 2018 Feb 27. Dig Liver Dis. 2018. PMID: 29567413
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
